TBL-100

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTBL-100
Drug Alias NameTBL-100
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-TAU
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorthwest University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwest University
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A